Cardiology assessment
ECG and echocardiogram where indicated; cardiac stress test for higher-risk profiles. The named consultant cardiologist on the partner facility team reviews the case before clearance.
مسجّلة في لندنالعمليات في تركياشركاء معلنون4 لغات
Gastric sleeve in Turkey — what the mortality data shows and what ATDERA does differently
Gastric sleeve mortality in Turkey is one of the most-searched questions in UK bariatric care, and the answer is not the headline you may have read. The published Turkish bariatric literature is uneven, and patient outcomes track patient screening, facility class, and the post-operative pathway far more closely than they track geography. Reading the question through that lens — rather than as a country-vs-country comparison — is the change in framing this article is built around.
What the published mortality data actually shows
The honest answer to 'is gastric sleeve surgery in Turkey safe?' is that outcomes vary enormously between facility classes, and the published data subdivides accordingly. Reading the mortality figure without the underlying patient-selection and facility-class context produces a misleading number in either direction.
The cited single-centre Turkish series — Seyit and Alis, Annals of Saudi Medicine 40(4):310–315, 2020 (National Library of Medicine PMC7410219) — followed 120 patients undergoing laparoscopic sleeve gastrectomy at the Bakırköy Dr. Sadi Konuk Training and Research Hospital in Istanbul over five years post-operatively. The reported procedural mortality was 2.5 percent (three patients): two from leak-related sepsis and one from pulmonary embolism after discharge. The mean preoperative BMI of the cohort was 48.3. This is single-centre data, not a national benchmark; an audit of Turkish bariatric outcomes equivalent in scope to the NHS National Bariatric Surgery Registry is not currently in the public literature, and where ATDERA cannot publish a figure with confidence we say so rather than invent one.
What the high-profile UK news cases share — the BBC Northern Ireland 2023 case, the Sky News surgeon-warning piece, and similar reports — is that the patients involved typically had no documented multi-disciplinary pre-operative screening, were operated at standalone or short-stay clinics rather than JCI-accredited hospitals, university medical centres, or established teaching hospitals, and had no structured post-operative pathway in place once discharged. The headlines describe the worst end of the screening, facility, and pathway distribution; the published Turkish single-centre series describes establishments at the other end. Both are real, and the gap between them is the part of the story rarely covered in either set of reports.
Mortality also varies meaningfully by patient profile: BMI band, T2DM control, sleep-apnoea burden, cardiac history, and adherence to the pre-operative weight-loss programme. Centres of excellence operate exclusion criteria for patients in whom procedural risk outweighs metabolic benefit; brokerage-model providers often do not. The selection step itself is one of the most consequential predictors of outcome.
Why pre-operative screening is where the mortality gap actually lives
The single biggest predictor of bariatric mortality in any jurisdiction is patient selection. Generic Turkey clinics typically operate a one-page BMI threshold; the ATDERA Care Network applies a multi-disciplinary pre-operative assessment before any case is approved for surgery. The protocol below is the floor, not the ceiling — additional investigations are added where individual case findings warrant.
Endocrinology and metabolic review
Type-2 diabetes control, thyroid function, HbA1c band, and any pituitary or adrenal cause of obesity ruled out. Diabetic patients receive a tailored peri-operative glycaemic plan.
Pulmonology and sleep-apnoea screening
Polysomnography where obstructive sleep apnoea is suspected; CPAP optimisation pre-operatively for confirmed cases. Untreated severe OSA is a contraindication to elective bariatric surgery in any centre of excellence.
Mental health and consent capacity assessment
Screening for active untreated psychiatric illness, eating-disorder history, and capacity to consent to a lifelong post-operative regime. Mirrors NICE NG246 best practice.
Dietitian-led pre-operative optimisation
Two-week liver-shrinkage diet, post-operative dietary plan, and the lifelong micronutrient regime explained before the surgical date. The dietitian's plan is shared with the patient's UK GP on request.
DVT risk stratification
Caprini score equivalent assessment; mechanical and pharmacological prophylaxis plan defined pre-operatively, including post-flight DVT precaution.
Named consultant anaesthesia review
Pre-operative review by the named consultant anaesthetist who will be in theatre. Difficult-airway risk, peri-operative analgesia, and ICU step-down threshold defined before the surgical date.
How the operating environment affects outcomes
Facility class matters more than country. The published bariatric mortality data subdivides into five tiers; outcomes differ materially across them. The ATDERA Care Network operates exclusively at the top three.
- JCI-accredited hospitals
Joint Commission International accreditation requires documented standards across patient identification, medication safety, infection control, anaesthesia, and post-operative monitoring. Re-audit is independent and scheduled.
- University medical centres
Affiliated with a university faculty of medicine; clinical governance and audit cycles run alongside a teaching programme. Surgeon volumes are typically high and supervised registrar cover is structured.
- Established teaching hospitals
Multi-decade clinical pedigree, intensive-care unit on site, full imaging access (CT contrast for leak detection where indicated), and a documented complication management protocol.
- Standalone bariatric clinics
Often single-procedure focused; ICU access typically requires patient transfer. Accreditation status is variable and not always disclosed up-front. Outcome data is rarely published or audited externally.
- Mobile or itinerant operations
Mobile clinics, hotel-based pre-operative assessment, and short-stay surgical operations marketed predominantly through social media. The mortality differential between this class and the top three accounts for a disproportionate share of UK news-cycle case reports.
Beyond the headline accreditation tier, the operating-environment specifics that affect outcomes include: ICU step-down on standby for the first 24 hours post-operatively, a named consultant anaesthetist (not rotating CRNA cover), 24-hour structured observation before discharge to recovery accommodation, and on-site CT-contrast access for leak detection where clinically indicated. The ATDERA Care Network confirms each of these for any case before approval.
What 'gastric sleeve surgery ruined my life' usually means — and what we can honestly say about it
Around 720 people in the UK type that exact phrase into Google every month. The honest engagement with the search isn't to dismiss it; it's to understand what patients are actually experiencing when they reach for that language. In our experience, the phrase usually refers to one of four post-operative outcomes — none of which is mortality, all of which deserve clear answers up front.
Weight regain in years two to five
The most common reason for the search. Roughly thirty percent of patients regain a quarter or more of their lost weight by year five if the post-operative behavioural and nutritional regime is not sustained. Bariatric surgery is metabolic surgery, not a one-shot solution.
ATDERA pathway: Structured remote review at week one, week six, and month three; UK-side dietitian referral arrangement at month six and month twelve; revisional surgery options discussed only after non-surgical interventions are exhausted.
New or worsening reflux (GERD)
Roughly ten to twenty percent of sleeve patients develop new or worsening gastro-oesophageal reflux. Most cases are managed medically with proton-pump inhibitors and dietary adjustment; a small minority eventually require revision to a bypass procedure.
ATDERA pathway: Pre-operative endoscopy where indicated, GERD risk discussed during case review, and a defined revision-pathway disclosure if the sleeve is later judged inadequate.
Long-term micronutrient deficiency
Vitamin B12, iron, calcium, and vitamin D deficiency are predictable and preventable. They become problematic only when the lifelong micronutrient regime lapses, which most commonly happens between year three and year five when the patient feels well and disengages from clinical follow-up.
ATDERA pathway: The post-operative regime is documented in writing, summarised for the patient's UK GP, and reinforced in the structured follow-up cadence. The protocol mirrors the standard UK private practice would issue.
Loose skin and body-image disconnect
Cosmetic rather than clinical, but often the most psychologically difficult outcome — particularly for patients who lost a large absolute weight. Skin elasticity does not recover after a certain point; body-contouring surgery is sometimes the only remediation.
ATDERA pathway: Pre-operative discussion sets realistic expectations. Body-contouring is referenced as a possible later intervention, not an automatic next step.
How the ATDERA Care Network differs from the broker model
UK private clinics rightly criticise the brokerage-model end of the Turkish bariatric market. Aggregator pricing, foreign-incorporated brokers, leisure-led marketing, and absent post-operative pathways are real and documented patterns. The comparison below sets out the structural differences between that baseline and how the ATDERA Care Network is configured. The differences are matters of organisational record, not marketing claims.
| UK clinic concern | Generic Turkey clinic | ATDERA model |
|---|---|---|
| Foreign jurisdiction with limited recourse if outcomes disappoint | Foreign-incorporated clinic, no UK regulatory presence | UK-incorporated (ATDERA GLOBAL LIMITED, Companies House 17173428); ICO-registered patient-data handling |
| Anonymous aggregator listings with no verified clinician accountability | Broker model; clinician revealed only after a deposit | Verified clinicians with verifiable credentials and written permission to publish; ATDERA Care Network roster |
| Discount-led positioning raises clinical-compromise questions | Leads with price-comparison claims and bundled packages | Evaluation-first model. Transparent expenditure ranges sourced to BDA 2024. No promotional framing. |
| Unclear or absent facility accreditation | Standalone clinics; accreditation status not disclosed | Treatment delivered at JCI-accredited facilities, university medical centres, leading teaching hospitals |
| No defined follow-up pathway once the patient is back home | Hand-off ends at the airport; UK-side aftercare uncoordinated | ATDERA Care Network coordinates the full pathway including UK-side follow-up |
| Travel-and-leisure framing positions medical care as a vacation product | Leads with leisure narrative and spa-style imagery | Clinical-education positioning. Same clinical bar as UK private practice. |
| Pre-operative screening rigour | Single-page BMI threshold and brief clinician assessment | Multi-disciplinary protocol: cardiology, endocrinology, sleep-apnoea screening, dietitian-led optimisation, mental-health and consent-capacity review, DVT risk stratification, named-consultant anaesthesia review |
| Anaesthesia oversight in theatre | Single rotating anaesthetist, ICU access typically requires inter-facility transfer | Named consultant anaesthetist who reviewed the case pre-operatively; ICU step-down on standby for the first 24 hours; on-site CT-contrast imaging for leak detection if clinically indicated |
| Post-operative pathway after discharge | Clinical hand-off ends when the patient is discharged to recovery accommodation; UK-side aftercare uncoordinated | Structured remote video review within 1st week, 6th week, and 3rd month post-operatively; UK-side aftercare summary issued to the patient's GP on request; ATDERA care coordinator is first port of contact for any post-op concern |
| Mortality and outcome data transparency | Internal audit data not published; outcome claims are typically self-reported and not externally verified | Programme cites peer-reviewed mortality data alongside verified partner clinicians' personal series; figures are sourced rather than asserted (NICE NG189, NLM-indexed bariatric series, ATDERA Care Network operating record) |
When bariatric surgery in Turkey is not the answer
The article would be incomplete without a clear contraindication list. Patients who fall into one of the categories below should not pursue bariatric surgery — in Turkey, in the UK private system, or anywhere else. Bringing this up here, before the enquiry form, is a deliberate choice: we lose the inappropriate cohort gracefully and build trust with the appropriate one.
BMI below the NICE NG246 threshold without comorbidities
BMI under 35 with no qualifying comorbidities (T2DM, severe OSA, controlled hypertension, joint-disease functional impairment) is below the threshold at which the metabolic benefit outweighs procedural risk. NICE NG246 sets the UK clinical standard.
Active untreated psychiatric illness affecting consent capacity
Bariatric surgery requires lifelong behavioural and dietary commitment. Active untreated mood disorder, eating-disorder relapse, or a current substance-misuse episode warrants stabilisation first, not surgery first.
Inability to commit to the lifelong micronutrient and dietary regime
If the pre-operative dietitian assessment indicates the patient cannot sustain the post-operative regime, surgery is the wrong intervention. Predictable non-adherence creates predictable harm.
Pregnancy or planned pregnancy within twelve months
Bariatric surgery is delayed until at least eighteen months post-partum and at least twelve months pre-conception, to avoid micronutrient depletion during foetal development. This is not a soft preference; it is a clinical contraindication.
Active substance dependency
Active alcohol or substance dependency requires recovery and stabilisation before any elective bariatric procedure. Post-operative substance use can produce severe consequences after sleeve gastrectomy.
Severe cardiac compromise unsuited to general anaesthesia
Where the cardiology pre-op flags general anaesthesia as high risk regardless of jurisdiction, the answer is not to seek a more permissive provider. The answer is to address the cardiac issue first and revisit bariatric surgery only when the anaesthetic risk profile changes.
A purely cosmetic motivation
Bariatric surgery is metabolic surgery — its purpose is the metabolic benefit of sustained weight loss, not body contouring. Patients seeking cosmetic body-shape change without metabolic indication are pointed toward the appropriate plastic-and-reconstructive pathway instead.
Frequently asked questions
Sources
Research
Clinical guidance
ATDERA GLOBAL LIMITED (Companies House #17173428, registered in England and Wales) is a UK-registered international healthcare coordination organisation; see the About ATDERA page for the registered structure and the Specialists page for verified partner clinicians. Care is delivered through the ATDERA Care Network of partner facilities in Turkey, and the standard medical disclaimer applies to the clinical content above. See also ATDERA’s UK cost-pillar guides: dental, rhinoplasty, IVF, laser eye surgery, and orthopedic. The information on this page is intended as an honest engagement with the published mortality and outcome data; it is not a substitute for personal clinical advice. Citations were verified against their published sources on 2026-05-06.
If you would like ATDERA's case review
Each case is reviewed by a verified partner bariatric clinician at a JCI-accredited or university-medical-centre partner facility before any travel plan is made. ATDERA returns a customised written estimate after the case review, with each cost component listed as a separate line item rather than a bundled headline figure.